Cytiva Upgrades Massachusetts CMO Site
Facility now totals 60,000 square feet and has bioprocessing capabilities ranging in scale from 10L to 2000L.
New Continuous Freeze-Dry Process for Single Vials
A continuous freeze-drier that moves single-dose vials along a track could help biomanufacturers improve product quality.
Axon to Leverage Existing CDMO Relationship for COVID Vaccine
Bachem, which has been working with Axon Neurosciences for more than 20 years, will play a critical role in manufacturing the vaccine for trials and beyond, specifically for production and initial commercial scaleup.
BIA Separations Introduces PrimaS Multi-Mode Ligand Bioprocess Technology
New platform designed to initially focus on high-resolution industrial scale processing of therapeutic mRNA.
Mass Spec’s Role in Bioprocessing
The technology’s versality and power can characterize complex mixtures such as proteomes and metabolomes.
Realizing the Virtues of Virtual
One of the biggest technical challenges of Bioprocessing 4.0 arises in turning an idea into practical reality.
Personalized Meds Will Drive Sector-Wide Bioprocessing Innovation
Precision medicine is extremely disruptive to the model of a blockbuster molecule produced in centralized facilities so that flexible tech and non-traditional sites will play a greater role.
Fujifilm to Invest $928 Million In Site Expansion
Move will double drug substance production capacity at facility in Denmark.
Keeping IgG2s Apart
Aggregation reduces the use of these antibodies, but one company seeks to change that.
